{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:38:21Z","timestamp":1790789901348,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/leu.2017.89","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T07:51:23Z","timestamp":1490082683000},"page":"2479-2490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Dnmt3a regulates T-cell development and suppresses T-ALL transformation"],"prefix":"10.1038","volume":"31","author":[{"given":"A C","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W C","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Nikitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mallaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E L","family":"Ostrander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Eultgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T E","family":"Druley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Challen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"BFleu201789_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nri2304","volume":"8","author":"I Aifantis","year":"2008","unstructured":"Aifantis I, Raetz E, Buonamici S . Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008; 8: 380\u2013390.","journal-title":"Nat Rev Immunol"},{"key":"BFleu201789_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","volume":"10","author":"F Radtke","year":"1999","unstructured":"Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, MacDonald HR et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10: 547\u2013558.","journal-title":"Immunity"},{"key":"BFleu201789_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX . The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216\u2013233.","journal-title":"Cell"},{"key":"BFleu201789_CR4","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1073\/pnas.0401133101","volume":"101","author":"YH Huang","year":"2004","unstructured":"Huang YH, Li D, Winoto A, Robey EA . Distinct transcriptional programs in thymocytes responding to T cell receptor, Notch, and positive selection signals. Proc Natl Acad Sci USA 2004; 101: 4936\u20134941.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201789_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/377355a0","volume":"377","author":"S Jarriault","year":"1995","unstructured":"Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A . Signalling downstream of activated mammalian Notch. Nature 1995; 377: 355\u2013358.","journal-title":"Nature"},{"key":"BFleu201789_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1101\/gad.960702","volume":"16","author":"B Reizis","year":"2002","unstructured":"Reizis B, Leder P . Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev 2002; 16: 295\u2013300.","journal-title":"Genes Dev"},{"key":"BFleu201789_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, JPt Morris, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu201789_CR8","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"WS Pear","year":"1996","unstructured":"Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183: 2283\u20132291.","journal-title":"J Exp Med"},{"key":"BFleu201789_CR9","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia\". N Engl J Med 2010; 363: 2424\u20132433.","journal-title":"N Engl J Med"},{"key":"BFleu201789_CR10","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research","year":"2013","unstructured":"Cancer Genome Atlas Research. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059\u20132074.","journal-title":"N Engl J Med"},{"key":"BFleu201789_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1101\/gad.186411.111","volume":"26","author":"C Simon","year":"2012","unstructured":"Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, Lemieux S et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev 2012; 26: 651\u2013656.","journal-title":"Genes Dev"},{"key":"BFleu201789_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clml.2015.11.003","volume":"16","author":"S Aref","year":"2016","unstructured":"Aref S, El Menshawy N, El-Ghonemy MS, Zeid TA, El-Baiomy MA . Clinicopathologic effect of DNMT3A mutation in adult T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 2016; 16: 43\u201348.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFleu201789_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronne","year":"2012","unstructured":"Couronne L, Bastard C, Bernard OA . TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med 2012; 366: 95\u201396.","journal-title":"N Engl J Med"},{"key":"BFleu201789_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/gcc.22039","volume":"52","author":"V Grossmann","year":"2013","unstructured":"Grossmann V, Haferlach C, Weissmann S, Roller A, Schindela S, Poetzinger F et al. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosomes Cancer 2013; 52: 410\u2013422.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu201789_CR15","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","volume":"208","author":"P Van Vlierberghe","year":"2011","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A, Haydu JE, Rigo I, Hadler M et al. ETV6 mutations in early immature human T cell leukemias. J Exp Med 2011; 208: 2571\u20132579.","journal-title":"J Exp Med"},{"key":"BFleu201789_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2012","unstructured":"Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS et al. \"Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2012; 44: 23\u201331.","journal-title":"Nat Genet"},{"key":"BFleu201789_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.exphem.2010.02.011","volume":"38","author":"GA Challen","year":"2010","unstructured":"Challen GA, Goodell MA . Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells. Exp Hematol 2010; 38: 403\u2013416.","journal-title":"Exp Hematol"},{"key":"BFleu201789_CR18","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1172\/JCI35090","volume":"118","author":"MY Chiang","year":"2008","unstructured":"Chiang MY, Xu L, Shestova O, Histen G, L'Heureux S, Romany C et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008; 118: 3181\u20133194.","journal-title":"J Clin Invest"},{"key":"BFleu201789_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.stem.2014.06.018","volume":"15","author":"GA Challen","year":"2014","unstructured":"Challen GA, Sun D, Mayle A, Jeong M, Luo M, Rodriguez B et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 2014; 15: 350\u2013364.","journal-title":"Cell Stem Cell"},{"key":"BFleu201789_CR20","doi-asserted-by":"publisher","first-page":"e1002781","DOI":"10.1371\/journal.pgen.1002781","volume":"8","author":"A Akalin","year":"2012","unstructured":"Akalin A, Garrett-Bakelman FE, Kormaksson M, Busuttil J, Zhang L, Khrebtukova I et al. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS Genet 2012; 8: e1002781.","journal-title":"PLoS Genet"},{"key":"BFleu201789_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood-2014-08-594648","volume":"125","author":"A Mayle","year":"2015","unstructured":"Mayle A, Yang L, Rodriguez B, Zhou T, Chang E, Curry CV et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood 2015; 125: 629\u2013638.","journal-title":"Blood"},{"key":"BFleu201789_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ccell.2016.05.003","volume":"29","author":"L Yang","year":"2016","unstructured":"Yang L, Rodriguez B, Mayle A, Park HJ, Lin X, Luo M et al. DNMT3A loss drives enhancer hypomethylation in FLT3-ITD-associated leukemias. Cancer Cell 2016; 29: 922\u2013934.","journal-title":"Cancer Cell"},{"key":"BFleu201789_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu201789_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147\u2013156.","journal-title":"Lancet Oncol"},{"key":"BFleu201789_CR25","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","volume":"121","author":"M Neumann","year":"2013","unstructured":"Neumann M, Heesch S, Schlee C, Schwartz S, Gokbuget N, Hoelzer D et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood 2013; 121: 4749\u20134752.","journal-title":"Blood"},{"key":"BFleu201789_CR26","doi-asserted-by":"publisher","first-page":"14920","DOI":"10.1073\/pnas.2436557100","volume":"100","author":"LC Murtaugh","year":"2003","unstructured":"Murtaugh LC, Stanger BZ, Kwan KM, Melton DA . Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA 2003; 100: 14920\u201314925.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201789_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/1074-7613(95)90113-2","volume":"3","author":"BJ Calnan","year":"1995","unstructured":"Calnan BJ, Szychowski S, Chan FK, Cado D, Winoto A . A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995; 3: 273\u2013282.","journal-title":"Immunity"},{"key":"BFleu201789_CR28","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1084\/jem.183.4.1879","volume":"183","author":"T Zhou","year":"1996","unstructured":"Zhou T, Cheng J, Yang P, Wang Z, Liu C, Su X et al. Inhibition of Nur77\/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med 1996; 183: 1879\u20131892.","journal-title":"J Exp Med"},{"key":"BFleu201789_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0092-8674(04)00162-X","volume":"116","author":"B Lin","year":"2004","unstructured":"Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77\/TR3. Cell 2004; 116: 527\u2013540.","journal-title":"Cell"},{"key":"BFleu201789_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20080101","volume":"205","author":"J Thompson","year":"2008","unstructured":"Thompson J, Winoto A . During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J Exp Med 2008; 205: 1029\u20131036.","journal-title":"J Exp Med"},{"key":"BFleu201789_CR31","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.4049\/jimmunol.0900894","volume":"183","author":"A Wang","year":"2009","unstructured":"Wang A, Rud J, Olson CM Jr., Anguita J, Osborne BA . Phosphorylation of Nur77 by the MEK-ERK-RSK cascade induces mitochondrial translocation and apoptosis in T cells. J Immunol 2009; 183: 3268\u20133277.","journal-title":"J Immunol"},{"key":"BFleu201789_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1126\/science.7624775","volume":"269","author":"SL Lee","year":"1995","unstructured":"Lee SL, Wesselschmidt RL, Linette GP, Kanagawa O, Russell JH, Milbrandt J . Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 1995; 269: 532\u2013535.","journal-title":"Science"},{"key":"BFleu201789_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1074-7613(02)00474-0","volume":"17","author":"TM Schmitt","year":"2002","unstructured":"Schmitt TM, Zuniga-Pflucker JC . Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002; 17: 749\u2013756.","journal-title":"Immunity"},{"key":"BFleu201789_CR34","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nchembio.106","volume":"4","author":"Y Zhan","year":"2008","unstructured":"Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol 2008; 4: 548\u2013556.","journal-title":"Nat Chem Biol"},{"key":"BFleu201789_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood-2014-08-594564","volume":"125","author":"H Celik","year":"2015","unstructured":"Celik H, Mallaney C, Kothari A, Ostrander EL, Eultgen E, Martens A et al. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Blood 2015; 125: 619\u2013628.","journal-title":"Blood"},{"key":"BFleu201789_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain DA, Spencer DH, Young MA, Lamprecht TL, Miller CA, Fulton R et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 2014; 25: 442\u2013454.","journal-title":"Cancer Cell"},{"key":"BFleu201789_CR37","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2013-02-483487","volume":"122","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Zhao H, Hardikar S, Singh AK, Goodell MA, Chen T . A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 2013; 122: 4086\u20134089.","journal-title":"Blood"},{"key":"BFleu201789_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.cell.2017.01.021","volume":"168","author":"DH Spencer","year":"2017","unstructured":"Spencer DH, Russler-Germain DA, Ketkar S, Helton NM, Lamprecht TL, Fulton RS et al. CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression. Cell 2017; 168: 801\u2013816.","journal-title":"Cell"},{"key":"BFleu201789_CR39","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/leu.2016.29","volume":"30","author":"L Scourzic","year":"2016","unstructured":"Scourzic L, Couronne L, Pedersen MT, Della Valle V, Diop M, Mylonas E et al. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice. Leukemia 2016; 30: 1388\u20131398.","journal-title":"Leukemia"},{"key":"BFleu201789_CR40","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1038\/ncomms10924","volume":"7","author":"J Koya","year":"2016","unstructured":"Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T et al. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nature Commun 2016; 7: 10924.","journal-title":"Nature Commun"},{"key":"BFleu201789_CR41","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O","volume":"86","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S et al. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer 1999; 86: 1216\u20131230.","journal-title":"Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201789","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.89","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/leu201789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:33:23Z","timestamp":1648748003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFleu201789"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.89","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"assertion":[{"value":"16 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}